Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07853040) titled 'A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Incyte Corporation
Condition:
Hepatic Insufficiency
Liver Diseases
Intervention:
Drug: INCB161734
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: October 13, 2026
Target Sample Size: 24
To know more, visit https://clinicaltrials.gov/study/NCT07853040
Disclaimer: Curated by HT S...